Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sut Leng Lei"'
Autor:
Ying Liu, Ella Man-Wai Un, Ying Bai, Man Keong Chan, Luo Xin Zeng, Sut Leng Lei, Junjun Li, Carolina Oi Lam Ung
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 27 (2024)
Introduction: Fetal growth restriction (FGR) is associated with a higher risk of perinatal morbidity and mortality, as well as long-term health issues in newborns. Currently, there is no effective medicine for FGR. Phosphodiesterase-5 (PDE-5) inhibit
Externí odkaz:
https://doaj.org/article/6e45504b1d7e4c1d822e90803a92d1c9
Autor:
Hao Hu, Carolina Oi Lam Ung, Afonso Cavaco, Zhi Feng Cen, Pou Kuan Tang, Luoxin Zeng, Sut Leng Lei
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Objectives The study aimed to determine how eHealth was adopted in pharmaceutical care (PC), the outcome reported and the contextual factors.Design Systematic literature review in accordance with the Preferred Reporting Items for Systematic Reviews a
Externí odkaz:
https://doaj.org/article/3b23a97497d24e54a5d0237ffb796e73
Autor:
Ying Liu, Ella Man-Wai Un, Ying Bai, Man Keong Chan, Luo Xin Zeng, Sut Leng Lei, Junjun Li, Carolina Oi Lam Ung
Background The efficacy and safety of phosphodiesterase-5(PDE-5) inhibitors in the management of fetal growth restriction (FGR) remains inconclusive and new evidence continues to emerge. This study aimed to evaluate the most recent evidence about the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1817f95516782fca46ce753ef286d005
https://doi.org/10.21203/rs.3.rs-2430583/v1
https://doi.org/10.21203/rs.3.rs-2430583/v1
Autor:
Zhi Feng Cen, Pou Kuan Tang, Hao Hu, Afonso Cavaco, Luoxin Zeng, Sut Leng Lei, Carolina Oi Lam Ung
Publikováno v:
BMJ open. 12(11)
ObjectivesThe study aimed to determine how eHealth was adopted in pharmaceutical care (PC), the outcome reported and the contextual factors.DesignSystematic literature review in accordance with the Preferred Reporting Items for Systematic Reviews and